Recruitment Job Decription Template Standard April 2017
Total Page：16
File Type：pdf, Size：1020Kb
JOB DESCRIPTION Consultant in Clinical Oncology 1. THE POST This is a consultant post in Clinical Oncology based at the Bristol Haematology and Oncology Centre (BHOC) with some sessions at Weston Area Health NHS Trust (WAHT) due to the cancer pathways across Bristol and the local region. The post is for a permanent (10PA) Clinical Oncologist with specialist skills in the management of upper gastrointestinal (GI) and Urology cancers. The post-holder will join specialised teams for the delivery of care of patients with upper GI cancer and Urology cancer. The contract will be held with the University Hospitals Bristol NHS Foundation Trust (UH Bristol) with an honorary contract at Weston Area Health Trust NHS Trust. The essential and desirable requisites are tabulated in Appendix A. Any applicant who is unable for personal reasons, to work full-time will be eligible to be considered for the post. If such a person is appointed, modification of the job content will be discussed on a personal basis with the Trust in consultation with consultant colleagues. 2. UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST (UHBristol) University Hospitals Bristol NHS Foundation Trust is a dynamic and thriving group of hospitals in the heart of Bristol, a vibrant and culturally diverse city. Our 9,000 staff offer over 100 different clinical services across nine different sites. We provide general medical and emergency services to the local population of Central and South Bristol, and a broad range of specialist services across a region that extends from Cornwall to Gloucestershire, into South Wales and beyond. We are one of the country's largest acute NHS Trusts with a 2016/2017 budget of £630 million. Our staff have developed leading edge services such as cardiac surgery and bone marrow transplantation that have built an international reputation and are in demand by patients from across the country. With strong links to the University of Bristol and University of West of England we are the major medical research centre in the region. The findings allow us to continually improve our patient care. Our academic links also make us the largest centre for medical training in the South West, attracting the highest calibre clinical staff from across the UK. We aim to provide healthcare, research and teaching of the very highest quality and are recognised as one of the highest-performing Acute trusts in the country. UH Bristol was V1.2 – April 2017 rated Outstanding by the Care Quality Commission (CQC) following an inspection in November 2016. As a Foundation Trust, UH Bristol is accountable to the local community and patients. The community and patients are invited to become members of the Trust and currently the Trust has 8,500 members. The membership, which includes staff members, voted in a formal election for governors to represent them on the Membership Council which sits alongside the Trust Board. The Council advises the Board on strategic direction and members and governors are active in improving the services at the Trust. The Trust structure is based on five autonomous Clinical Divisions: . Medicine and Emergency Care . Surgical Division . Women’s and Children’s Services . Specialised Services . Diagnostic and Therapy Services A clinical chair supported by a Divisional Director leads each Division. The Divisions are supported by a sixth Division - Trust Services which comprises of a number of corporate functions including Finance, IM&T, and Human Resources. 3. UNIVERSITY OF BRISTOL LINKS The University of Bristol offers an exciting academic environment with centres of excellence in all of its faculties. It also has an ambitious programme for expansion and a well- established major “campaign for resources” to facilitate future developments. The University is in the city centre and the Medical School and basic science departments are within walking distance of UHBristol. Bristol is one of the few universities with schools of medicine, dentistry and veterinary science, all in close proximity. The Medical School has an intake of 250 students each year to its undergraduate medical course following recent expansion. The Dental School has also recently expanded and now has an intake of 75 undergraduate students per year. The Faculty’s research philosophy is to undertake internationally recognised basic and applied medical and health services within a setting which patients are cared for in association with undergraduate teaching and postgraduate training. 4. THE DIVISION OF SPECIALISED SERVICES The BHOC is in the Division of Specialised Services (Divisional Chair, Mr Alan Bryan; Divisional Director, Mr Owen Ainsley). This Division employs around 800 staff working in Clinical and Medical Oncology, Clinical Haematology, Palliative care, Homeopathy, Cardiac Surgery, Cardiology, Cardiac Anaesthesia and Intensive Care. All these services have a specialised nature in common, offering treatment for regional, network and supra-network catchment populations. We work closely with local commissioners, specialist V1.2 – April 2017 commissioners, cardiac networks and private service providers to provide high quality care in an appropriate setting, with the relevant expertise. 5. THE WORK OF THE DEPARTMENT The BHOC provides Oncology services to the former Avon, Somerset and Wiltshire Cancer Network with a catchment population of approximately 2.2 million people. At present the non-surgical oncology service for Bristol is currently provided by 16 clinical and 5 medical oncologists (approximately 20 whole time equivalents). The centre provides radiotherapy (adult and children), brachytherapy and chemotherapy (adult) services to all the Bristol hospitals. Chemotherapy services are also provided in Weston General Hospital. This structure allows the BHOC to further develop the infrastructure for specialist service support and provision. The BHOC is also the home of the Avon Haematology Unit (AHU) providing a full range of treatments (including autologous Bone Marrow Transplant Services), the University of Bristol Palliative Medicine group and a large Clinical Trials Unit. The BHOC is managed by a Clinical Director (Dr Steve Robinson) reporting to the Divisional Board, supported by a BHOC General Manager (Ms Sophie Baugh). The operating budget is currently £39 million. There is a senior management team made up of the Clinical Director, General Manager, Clinical Leads for Chemotherapy and Radiotherapy, Leads for Haematology, Oncology and Palliative Medicine, Radiotherapy Services Manager and Matron. This team, along with the Divisional Director, Divisional Finance Manager, Head of Nursing and HR Business Partner are members of the BHOC Executive Group, which is the formal decision-making body reporting to the Divisional Board. The programme of consultant expansion across Bristol over the next few years will improve patient care by: 1. Addressing areas of excessive and inequitable workload amongst existing consultants. 2. Increasing tumour site specialisation in consultant teams. 3. Increasing specialist non-surgical oncology input into multidisciplinary teams. 4. Improving training at all levels. 5. Increasing the number of patients recruited to clinical trials. 6. Developing the regional research collaborative and early phase studies. Clinical: There is a 32 bedded oncology ward incorporating 5 teenage and young adult (TYA) beds with two protected sealed/unsealed source rooms, an out-patient suite and a chemotherapy day unit for oncology patients. The Haematology Unit consists of a 23 bedded ward and day units for patients with both malignant and non-malignant disorders. The Bristol Haemophilia Comprehensive Care Centre and Bone Marrow Transplant service are based on the unit. Diagnostic radiology: The centre houses a diagnostic x-ray unit for plain radiography. There is also a spiral CT scanner based in the centre for radiotherapy planning, with a second CT scanner being installed this year. MRI, CT and nuclear medicine scanning are available in the adjacent Bristol Royal Infirmary on the same campus. V1.2 – April 2017 Radiotherapy/physics: There are 5 linear accelerators, 3 of dual energy and 4 have electrons. Megavoltage portal imaging is available on all machines and cone beam CT on 3 machines. A new linac has been recently installed in one of the new bunkers with a further replacement linac planned for 2017. There is also a Varian HDR GammaMed machine. The mould room supports a full range of customised patient immobilisation and beam direction devices. Fully 3-dimensional CT/MRI based conformal radiotherapy is available for most radical treatments, as appropriate. The department has a Gamma Knife Perfexion unit to provide intra-cranial stereotactic radiosurgery. IMRT is routine practice in most tumour sites and SABR is well established, with Bristol being the leading centre for the southwest. The computerised treatment planning system is Oncentra Masterplan (due to be replaced with Raystation in 2018) and Brachyvision for brachytherapy. Clinical Trials Unit: The BHOC has a major commitment to clinical research and there is a very active Clinical Trials Unit, led by Dr Axel Walter and managed by Senior Manager, Heather Carroll. The Unit employs site specialist teams of nurses, trial co-ordinators and radiographers. It currently runs approximately 100 active studies and recruitment exceeds NCRI targets. Its infrastructure supports the cancer service and is fully integrated into BHOC multi-disciplinary team, it plays an important role in the Local Comprehensive